DNA 시퀀싱용 모바일 앱 시장

The global market for mobile apps for DNA sequencing was valued at an estimated $777.1 million in 2025 and is estimated to increase from $934.9 million in 2026 to reach $2.4 billion by the end of 2031, at a compound annual growth rate (CAGR) of 21.1% from 2026 to 2031.

Report Scope

The scope of the global mobile apps for DNA sequencing market includes several major domains:

• DNA sequencing technologies.
• Genomic data analysis and bioinformatics.
• Genetic visualization tools.
• Consumer genomics and genealogy.
• Family tree and ancestry mapping.
• Clinical diagnostics and precision medicine.
• Cloud-based genomic platforms.

The report provides an overview of the global mobile apps for DNA sequencing market and analyzes market trends. The report includes global revenue ($ million) for the base year data 2025 and estimated data for the forecast period 2026 through 2031. The market is segmented based on platform, technology type, end-use, and regions. The regions covered in this study include North America, Europe, Asia-Pacific, and the Rest of the World, focusing on major countries in these regions.

The report focuses on the driving trends and challenges that affect the market and vendor landscape. It discusses emerging technologies related to the market. The report concludes with an analysis of the competitive landscape, which provides the ranking of key participants in the global mobile apps for DNA sequencing market. The company profiles section covers details such as overview, key financials, product portfolio, and recent developments of key market participants.

Report Includes

• 33 data tables and 34 additional tables
• An analysis of the global markets for mobile apps for DNA sequencing data analysis
• Analyses of the global market trends, with historic data from 2023 to 2025, estimates for 2026 and projections of CAGRs through 2031
• Estimates of the market size and revenue prospects for the global market, accompanied by a market share analysis based on application platform, sequencing technology, end user, and region
• Facts and figures pertaining to the market dynamics, recent technological advancements in diabetes management, regulations, prospects and the impact of macroeconomic variables
• Insights derived from Porter's Five Forces model, as well as global supply chain analyses
• Review of emerging technologies, market applications, industry structure, and key initiatives in clinical sequencing
• Patent review, featuring key granted and published patents
• Analysis of the industry structure, including companies' market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
• Company profiles of major players within the industry including, Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies plc., and QIAGEN

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of the Report
• Market Summary
• Market Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Introduction
• Current and Future Market Overview
• Technology Background
• Industry Ecosystem
• Macro-economic Factors Analysis
• PESTEL Analysis
• Impact of U.S. Tariff Laws on the Mobile Apps for DNA Sequencing Market
• Porter's Five Forces Analysis
• Bargaining Power of Buyers: Moderate to High
• Bargaining Power of Suppliers: High
• Threat of Substitute: Moderate
• Threat of New Entrants: Moderate to High
• Industry Rivalry: High
• Supply Chain Analysis
• Upstream: Core Technology and Infrastructure Providers
• Data Infrastructure and Cloud Computing Layer
• Software Development and Integration Layer
• Distribution Channels
• Downstream: End Users and Application Sectors
• Regulatory and Compliance Overlay
• Key Supply Chain Characteristics
• Value Chain Analysis
• Inbound Activities (Inputs and Enablers)
• Core Development and Operations
• Support Functions (R&D, Compliance, Partnerships, Human Capital)
• Outbound Logistics and Delivery
• Marketing and Sales
• Service and Aftermarket Support

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Rising Adoption of Portable Sequencing Devices
• Advances in Cloud Computing and AI
• Declining Cost of DNA Sequencing
• Growing Investment in Genomics and Biotechnology Research
• Market Restraints
• Data Privacy and Security Concerns
• Limited Mobile Processing Capabilities
• Interoperability Issues
• Market Opportunities
• Growth in Emerging Markets
• Expansion into Point-of-Care Diagnostics
• Emergence of Portable Sequencing Devices

Chapter 4 Regulatory Landscape

• Overview
• U.S.
• Europe
• Asia-Pacific
• Rest of the World

Chapter 5 Emerging Technologies and New Developments

• Overview
• Portable Nanopore Sequencing
• Smartphone-Integrated Sequencing
• AI, Edge Computing, and On-Device Bioinformatics
• Real-Time Signal Processing of DNA Data

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown by Platform
• Key Takeaways
• Android
• iOS
• Market Breakdown by Technology Type
• Key Takeaways
• Next-Generation Sequencing (NGS)
• Third Generation Sequencing
• Sanger Sequencing
• Others
• Market Breakdown by End Users
• Key Takeaways
• Computational Biology/Rare Diseases
• Genealogy
• Geographic Breakdown
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 7 Competitive Intelligence

• Key Takeaways
• Top Participants Ranking, 2025
• Strategic Analysis
• Venture Fundings

Chapter 8 Appendix

• Methodology
• Abbreviations
• References
• Company Profiles
• 23ANDME RESEARCH INSTITUTE
• ANCESTRY
• DNANEXUS INC.
• HELIX INC.
• ILLUMINA INC.
• M42
• MYHERITAGE LTD.
• NEBULA GENOMICS
• OXFORD NANOPORE TECHNOLOGIES PLC.
• QIAGEN
• THERMO FISHER SCIENTIFIC INC.